Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
Analytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
Services professionnels
Témoignages clients
Newsroom
Blog
Rapport mondial sur l'innovation
Glossaire
Webinaires et formations
Frontière
Communauté d'utilisateurs
Confiance et sécurité
PatentBench
LLM
Centre d'aide
Carrières
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport Tirzepatide's SURPASS-CVOT trial examines GLP-1/GIP dual agonist cardiovascular and renal outcomes in type 2 diabetes. Explore the science, IP landscape, and clinical significance.
Article | Rapport How do open-source and proprietary LLMs differ for enterprise R&D? Compare customisation, cost, compliance, and performance to make smarter AI deployment decisions.
Article | Rapport Sparsentan targets both ETA and AT1 receptors for FSGS and IgAN treatment. Explore the dual receptor antagonism mechanism, IP landscape, and clinical signals.
Article | Rapport IMerge Phase 3 trial: imetelstat achieved 39.8% 8-week transfusion independence vs 15% placebo in lower-risk MDS. Full pipeline analysis and biomarker data.
Article | Rapport Key design considerations for thermal management in next-generation AI server rack deployments — cooling strategies, power density challenges, and engineering frameworks.
Article | Rapport How olutasidenib differs from ivosidenib in IDH1-mutated relapsed AML, plus emerging combination strategies with venetoclax and azacitidine.
Article | Rapport No verified patent or literature data was available to support a sourced article on ToF vs structured light inline metrology. Learn why evidence-based reporting matters.
Article | Rapport What stops green hydrogen reaching $2/kg? Explore the key engineering, materials, and systems barriers — from electrolyzer efficiency to membrane degradation.
Article | Rapport Intellia's NTLA-2002 (Lonvo-Z) targets KLKB1 via CRISPR-Cas9 in vivo editing for HAE. Explore the Phase III pipeline, mechanism, and IP landscape.
Article | Rapport Deucravacitinib's TYK2 inhibitor expansion into PsA, SLE, and IBD: POETYK, PAISLEY trial data, competitive readouts, and what 2026 means for the class.
Article | Rapport WAAM vs powder bed fusion for large structural parts: compare deposition rates, scalability, cost, and material performance to choose the right AM process.
Article | Rapport Mapping the 2026 offshore hydrogen production patent landscape: platform electrolysis, seawater splitting, LOHC export, and the key assignees driving innovation at sea.
Article | Rapport Ianalumab's FDA review for Sjögren's disease marks the first targeted BAFF-R biologic approach to this autoimmune condition. Explore the science and IP landscape.
Article | Rapport No source data was provided for this topic. Resubmit with populated patent and literature results to generate a fully referenced technical article.
Article | Rapport Explore the core engineering challenges of achieving consistent weld quality in robotic laser welding of battery enclosures — from defect control to adaptive process monitoring.